abnormal basal ganglion morphology_Cln3<tm1Nbm>/Cln3<tm1Nbm>

http://metadb.riken.jp/0006007I129S6SvEvTacNIHBlackSwissCln3tm1NbmCln3tm1NbmCln3tm1Nbm

abnormal basal ganglion morphology_Cln3<tm1Nbm>/Cln3<tm1Nbm>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• ceroid lipofuscinosis, neuronal 3, juvenile (Batten, Spielmeyer-Vogt disease)
  http://metadb.riken.jp/db/mgi_rdf/MGI:107537

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Cln3<tm1Nbm>/Cln3<tm1Nbm>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Cln3<tm1Nbm>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129S6/SvEvTac * NIH Black Swiss

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• abnormal basal ganglion morphology
  http://purl.obolibrary.org/obo/MP_0006007

文献

http://purl.org/net/cito/citesAsAuthority

• H M. Mitchison, et.al., Targeted disruption of the Cln3 gene provides a mouse model for Batten disease. The Batten Mouse Model Consortium [corrected]., Neurobiology of disease, 1999, 6
  http://rdf.ncbi.nlm.nih.gov/pubmed/10527801